相关临床试验
106
74 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
N/A
进行中（未招募）
6
5.7%
已完成
14
13.2%
尚未招募
68
64.2%
招募中
18
17.0%
暂无批准数据
- The Australian TGA reports a total of 11 possible liver injury cases linked to ashwagandha-containing products, with 4 new cases since its 2024 safety advisory. - All four new cases resolved upon discontinuation without hospitalization, though two prior Australian cases required hospital care and one international case required a liver transplant. - The TGA states the risk appears "very rare" but will continue assessing emerging evidence to determine if further regulatory action is necessary. - Concurrently, ashwagandha stakeholders met with EU policymakers to discuss a potential Article 8 review, while India's Ministry of Ayush maintains root extract is safe for human consumption.
- India has announced the world's first clinical study to scientifically evaluate Ayurveda as an adjunct to standard Anti-Tuberculosis Treatment, marking a historic convergence of traditional medicine and modern biotechnology. - The landmark study will enroll 1,250 newly diagnosed TB patients across eight premier institutions, focusing on nutritional recovery, disease progression, quality of life improvements, and safety of integrative therapy. - India accounts for approximately 25% of the global TB burden but has achieved a 21% decline in incidence since 2015, with TB cases reduced to 187 per 100,000 population in 2024. - The collaborative initiative between the Department of Biotechnology and Ministry of Ayush will deploy advanced scientific tools including DEXA scans, MRI, immune profiling, and single-cell RNA sequencing to evaluate outcomes.
- Body Revival, an Ayurvedic herbal formulation containing nine traditional herbs, has successfully completed Phase II clinical trials demonstrating significant benefits for breast cancer patients undergoing conventional treatment. - The 12-week trial at J.B. Roy State Ayurvedic Medical College involved 44 breast cancer patients, showing improvements in quality of life metrics and key blood parameters during chemotherapy and radiation. - The proprietary micro-herbal solution, developed over 25 years of research, combines traditional ingredients like Ashwagandha and Bael with modern scientific methodology to address cancer care challenges.
